Group 1 - China's largest offshore floating liquefied natural gas facility, NGUYA (恩古雅) FLNG, has been launched in Nantong, marking a significant advancement in the country's energy infrastructure [3] - The facility is designed to have the largest tonnage and storage capacity, indicating a strong commitment to enhancing natural gas supply capabilities [3] - Key figures from the event included local government officials and representatives from international energy companies, highlighting collaboration in the energy sector [3] Group 2 - Nantong's economy has shown resilience and potential, with steady growth in major sectors such as industry, services, and foreign trade [5] - The local government plans to continue reinforcing the economic recovery and leverage policy effects to promote further development [5] - The construction of the Jiangsu Changjiang Sports Park, a key ecological project, is set to enhance recreational spaces for residents, reflecting a focus on sustainable urban development [6] Group 3 - Two innovative medical devices have received approval from the National Medical Products Administration, showcasing advancements in the healthcare sector [6] - The approved devices include a cerebral aneurysm embolization stent and a pulmonary artery thrombectomy stent system, indicating growth in the medical technology industry [6] Group 4 - The upcoming 2025 Haimen Marathon will creatively incorporate the local textile industry, introducing a DIY textile bib number for participants, which may enhance community engagement and promote local culture [6][7] - The opening of two new high-standard school campuses in Chongchuan District is expected to improve educational resources and infrastructure, contributing to the region's educational development [7]

Group 1 - Jiangsu Changyida Medical Technology Co., Ltd. and Morningstar (Nantong) Medical Device Co., Ltd. have received approval from the National Medical Products Administration for their innovative Class III medical devices, namely the "Intracranial Aneurysm Assisting Embolization Stent" and the "Pulmonary Artery Thrombectomy Stent System" respectively [1][2] - In 2023, a total of 9 innovative Class III medical devices have been approved for market entry in Jiangsu Province [1] - The "Intracranial Aneurysm Assisting Embolization Stent" features a self-expanding elastic structure with adjustable length and flared ends, aimed at reducing vascular damage and enhancing vascular adhesion [1] Group 2 - The "Pulmonary Artery Thrombectomy Stent System" is designed for mechanical thrombectomy via the femoral vein, utilizing a large-caliber thrombus suction catheter to quickly restore blood flow [2] - This device offers a short preoperative preparation time, high efficiency in thrombus removal during the procedure, and rapid postoperative recovery [2] - The stent system includes various models with a gradient design for the mesh disk, which is intended to be more compatible with target blood vessels and reduce the risk of vascular damage [2] Group 3 - The Jiangsu Provincial Drug Administration is focusing on core technology breakthroughs and addressing "bottleneck" technologies to promote innovative medical device development [3] - The administration aims to enhance the transformation of clinical research results into practical applications, fostering collaboration between medical and industrial sectors [3] - Efforts are being made to reform the review and approval system, optimize the industrial ecosystem, and increase the international competitiveness of high-end medical devices in Jiangsu Province [3]